PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
Ccent/2024/15 - Lusopalex / Arium
Acquired
Arium - Sistemas de Diagnóstico, Lda.
Description
It operates in Portugal in the wholesale distribution of medical devices and medical devices for in vitro diagnostics.
Acquiring
Lusopalex - Produtos de Saúde Unipessoal, Lda.
Description
Active in Portugal in the wholesale distribution of medical devices, medical devices for in vitro diagnostics and medicines for human use in the area of nuclear medicine.
Sector
  • Health & Pharmaceutical
Activity (NACE)
Applicable legislation
Art. 37(1)(a) and (c) (Law 19)
Notification thresholds
Market Share and Turnover thresholds
Type of merger
Horizontal
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Non-opposition
Case description

The merger operation consists of the acquisition, by Lusopalex – Produtos de Saúde Unipessoal, Lda. (“Lusopalex”), a Palex Group company, of the exclusive control of Arium – Sistemas de Diagnóstico, Lda. (“Arium”).
Timeline
2024-04-08
The AdC issued a non-opposition decision to the merger 15/2024 - Lusopalex / Arium.
2024-03-15
Lusopalex notifies the acquisition of exclusive control over Arium.
Click here to see your activities